Cite

HARVARD Citation

    Li, S. et al. (2020). Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling. EMBO molecular medicine. 12 (9), p. n/a. [Online]. 
  
Back to record